Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

DNA interval in unexplored region of human genome increases risk for coronary artery disease

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have learned how an interval of DNA in an unexplored region of the human genome increases the risk for coronary artery disease, the leading cause of death worldwide.

23 Feb 2010

New cardiac imaging technique reduces radiation exposure compared to standard helical scan

In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.

23 Feb 2010

Two genetic alterations linked to benign enzyme condition keep hepatitis C patients anemia-free

Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists in Duke University's Institute for Genome Sciences & Policy have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anemia-free.

21 Feb 2010

Study reveals underrepresentation of women in cardiovascular clinical trials

Women are substantially underrepresented in clinical trials used to formulate women's guidelines and are affected more than men by low social support after a heart attack, according to two studies in the women-themed issue of Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

20 Feb 2010

Cappella promotes serial IVUS analysis & Sideguard 3.25 device at Rome JIM

Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.

20 Feb 2010

Researchers identify specific metabolic profiles that predict risk of heart attack and death

Tiny bits of molecular "trash" found in circulating blood appear to be good predictors of cardiovascular disease and untimely death, say researchers at Duke University Medical Center.

19 Feb 2010

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in Portugal and Austria.

19 Feb 2010

Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.

18 Feb 2010

Generx clinical development opportunities: bioRASI to assist Cardium

Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.

17 Feb 2010

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women's HealthSource.

12 Feb 2010

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.

10 Feb 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

Simple, inexpensive test for diagnosing cardiac-related chest pain

Researchers at the Methodist DeBakey Heart & Vascular Center have shown that a simple, inexpensive test can determine whether it is safe to send home a patient who comes to the emergency room with chest pain.

9 Feb 2010

Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedule

Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.

9 Feb 2010

Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study

Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.

8 Feb 2010

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Stereotaxis today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located in Taipei. CHMC hosted a Grand Opening event on January 26 that received wide coverage throughout the area and, to date, ten procedures have been successfully performed using Stereotaxis at the hospital.

8 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

Personalized risk assessment tools can help improve smoking cessation

Giving smokers information about their own individual risk of serious illness helps motivate them to quit smoking, according to a paper published in the current issue of Postgraduate Medical Journal.

5 Feb 2010

CCHP implements TriZetto systems to improve its network and health management programs

The TriZetto Group, Inc. today announced that Chinese Community Health Plan (CCHP) has successfully implemented several TriZetto systems, including the Facets®, NetworX Pricer® and Clinical CareAdvance® applications.

5 Feb 2010

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test.

5 Feb 2010

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

DNA interval in unexplored region of human genome increases risk for coronary artery disease

New cardiac imaging technique reduces radiation exposure compared to standard helical scan

Two genetic alterations linked to benign enzyme condition keep hepatitis C patients anemia-free

Study reveals underrepresentation of women in cardiovascular clinical trials

Cappella promotes serial IVUS analysis & Sideguard 3.25 device at Rome JIM

Researchers identify specific metabolic profiles that predict risk of heart attack and death

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

Generx clinical development opportunities: bioRASI to assist Cardium

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Simple, inexpensive test for diagnosing cardiac-related chest pain

Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedule

Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Personalized risk assessment tools can help improve smoking cessation

CCHP implements TriZetto systems to improve its network and health management programs

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in